DGCI Current Affairs, GK & News

Vice President launched ‘Vaccinate India Programme’

Vice President of India, M. Venkaiah Naidu, launched “Vaccinate India Programme” on August 24, 2021. On the occasion, he appealed to the people to strictly follow COVID-19 norms. Key points This programme was organised by Give India Foundation and Sustainable Goals Coordination Centre in Bengaluru. It was launched under CSR in association with Planning Department ..

Month: 

Category: 

Topics: 

DCGI approves ZyCoV-D vaccine for Emergency Use Authorization

The Drug Controller General of India (DGCI) has approved ZyCoV-D vaccine by Zydus Cadila for Emergency Use Authorization. Key Points According to Ministry of Science and Technology, ZyCoV-D vaccine is the world’s first and India’s indigenously developed DNA-based vaccine for COVID-19. It will be administered to humans including children and adults aged 12 years and ..

Month: 

Category: 

Topics: 

Zydus drug Virafin gets DCGI nod

The Drug Controller General of India recently provided “Restricted Emergency Use Approval” for the use of “Virafin”. Virafin is used to treat Hepatitis B and C. Now it is to be used to treat moderate COVID-19 infections. About Virafin A single dose of Virafin during the early stage of infection, will help COVID-19 patients recover ..

Month: 

Category: 

Topics: 

India approved two COVID-19 vaccines for Emergency Use

The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved by DGCI for emergency use? COVAXIN and COVISHIELD What is COVAXIN? The COVAXIN is the COVID-19 vaccine developed by Bharat Biotech and ICMR (Indian council of Medical ..

Month: 

Category: 

Topics: